PHS
SGEN

PFM Health Sciences’s Seagen Inc. Common Stock SGEN Stock Holding History

PFM Health Sciences’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,000
Closed -$7.08M – 94
2022
Q2 		$7.08M Buy
+40,000
New +$5.76M 0.27% 68

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

PFM Health Sciences's SGEN Position: Q4 2023 in Review

PFM Health Sciences sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 281,617 shares — an estimated $59.7M sold.

PFM Health Sciences first reported a position in SGEN in Q2 2021 and held it in 9 quarters. The position peaked at $76.3M in Q2 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • PFM Health Sciences reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • PFM Health Sciences sold 281,617 Seagen Inc. Common Stock shares in Q4 2023, an estimated $59.7M.
  • PFM Health Sciences first reported a position in Seagen Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • PFM Health Sciences's Seagen Inc. Common Stock position peaked at $76.3M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.